RxSight, Inc.
NASDAQ•RXST
CEO: Dr. Ronald M. Kurtz M.D.
板块: Healthcare
行业: Medical - Devices
上市日期: 2021-07-30
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
联系方式
市值
$194.98M
市盈率 (TTM)
-4.2
40.4
股息率
--
52周最高
$14.88
52周最低
$4.48
52周范围
排名59Top 87.6%
2.2
F-Score
改良版 Piotroski 分析
基于 6 年期基本面
疲弱 • 2.2 / 9 分
评分区间 (0-9)
8-9: 价值优异
6-7: 基本面强劲
4-5: 整体稳健
0-3: 表现疲弱
数据范围: 2020-2025
深度研究
财务数据
电话会议
财务报告
新闻
利润表
资产负债表
现金流量表
财务比率
变化率
利润表 | 过去12个月 |
|---|
无数据